PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One pill to rule them all? new combo therapy for PAH shows promise
Disease control CompletedThis study tested a single pill combining two drugs (macitentan and tadalafil) for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. 187 adults with PAH took either the combination pill or one of the two drugs alone for 16 …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Breathe easy: slow breathing may ease PAH symptoms
Symptom relief CompletedThis study looked at whether doing slow-paced breathing exercises at home can help people with pulmonary arterial hypertension (PAH) manage symptoms like shortness of breath, fatigue, and poor sleep. 42 adults with stable PAH took part. The goal was to see if this simple techniqu…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
Ultrasound score may sharpen risk prediction in rare lung disease
Knowledge-focused CompletedThis study looked at 86 adults with pulmonary arterial hypertension (PAH) to see if a new ultrasound score called VExUS could help doctors better understand their risk. Researchers compared the VExUS score to standard tests like heart catheterization and blood markers. The goal w…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC